NewsRoom Articles - Page 1323 of 1390

ThursdayJan 12, 2017 11:03 am

Net Element, Inc. (NASDAQ: NETE) Subsidiary PayOnline Adds Russia’s Leading Short-Term Accommodation Rental Service as Client

Before the opening bell, Net Element, Inc. (NASDAQ: NETE) announced that its PayOnline subsidiary has entered into a new partnership with Sutochno.ru, Russia’s premier C2C short-term booking service, through which PayOnline will be providing online payment acceptance services for the platform. Similar to Airbnb, Sutochno.ru gives users the tools to book short-term accommodation in markets across Russia. The site currently features more than 70,000 property listings, and it attracted over 700,000 guests in 2016. Sutochno.ru differentiates itself from Airbnb by offering a more attractive pricing model that eliminates commission charges for guests and minimizes fees for hosts. Moving forward, PayOnline’s…

ThursdayJan 12, 2017 9:29 am

GainClients, Inc. (GCLT) has Disruptive Marketing Solutions for Real Estate Professionals

GainClients, Inc. (OTC: GCLT) is disrupting the real estate marketing and advertising industry. Its GCard mobile technology platform ‘allows the loan originator, the real estate sales person, or the “title guy” to succeed in this marketplace’. In an interview with RedChip (http://nnw.fm/23hTv), CEO of GainClients, Ray Desmond, discussed the concepts behind his company’s business model. GainClients, it appears, is attempting to monetize the store of data and knowledge amassed by CEO Ray Desmond over his 36 years in the real estate industry. “We’ve created our daily opportunities product that allows us to catch that person that’s selling their house that…

WednesdayJan 11, 2017 4:28 pm

Cytosorbents Corp. (NASDAQ: CTSO) Expected to Announce Doubling in Sales for 2016

Cytosorbents Corp. (NASDAQ: CTSO), a critical care-focused immunotherapy company engaged in the research, development, and commercialization of medical devices, most prominently its platform blood purification technology that incorporates a proprietary adsorbent polymer technology, recently pre-announced unaudited results (http://nnw.fm/P4Yaz) for fiscal 2016 ahead of its Form 10-K filing. Cytosorbents expects to announce between $8.1 and $8.3 million in Cytosorb sales for the whole of 2016. This equates to more than double the total from the previous year. Cytosorb is the company’s flagship product, a blood filter that helps treat deadly inflammation in critically-ill and cardiac surgery patients across the globe. In…

WednesdayJan 11, 2017 2:49 pm

Aegis Restates ‘Buy’ Rating on Shares of Rosetta Genomics Ltd. (NASDAQ: ROSG)

Rosetta Genomics, Ltd. (NASDAQ: ROSG), a company in the business of developing and commercializing MicroRNA-based and other molecular diagnostics, recently had its ‘Buy’ rating restated by Aegis Capital Corp. (http://nnw.fm/LV2Yy) with a price target of $3.50 per share. This was based on Aegis’ 2017 revenue estimate of $17.7 million with a multiple of 4X. The company update was released after Rosetta Genomics Ltd. announced a new collaboration to determine biomarkers that can predict response to Opdivo, a PD-1 immunotherapy. In addition to the above, Aegis Capital Corp. announced expectations for Rosetta Genomics’ cash deliverables to be over $9 million by…

WednesdayJan 11, 2017 2:15 pm

CytoDyn Inc. (CYDY) Requests FDA Breakthrough Therapy Designation for HIV-1 Treatment

Biotech company CytoDyn Inc. (OTCQB: CYDY) this morning announced that it has filed a request with the U.S. FDA for Breakthrough Therapy Designation for its lead product candidate, PRO 140, as a treatment for HIV-1 infection in treatment-experienced patients with virologic failure. The request stems from limitations with the current standard of care for HIV infection, which features a combination of medications from numerous antiretroviral classes that are known to interfere with individual steps of the HIV lifecycle. As the virus multiplies within the body, it sometimes mutates, producing variations of itself with drug-resistant characteristics that can limit the effectiveness…

WednesdayJan 11, 2017 1:49 pm

Trevena, Inc. (NASDAQ: TRVN) Completes Phase 3 Apollo Trials for Oliceridine, Says Athena Study on Track

Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company, on January 4 announced it had completed enrollment for its Phase 3 Apollo Pivotal Efficacy Trials of oliceridine for moderate to severe pain. Oliceridine (TRV 130) is Trevena’s lead product candidate. It was deemed “a breakthrough therapy by the U.S. Food and Drug Administration,” based on the results of earlier clinical trials, the company said (http://nnw.fm/q5XAK). “We are pleased to have completed enrollment in these important studies and to confirm that the Apollo trials remain on schedule to report top-line results in the first quarter of 2017,” Maxine Gowen, Ph.D., chief…

WednesdayJan 11, 2017 11:19 am

eXp World Holdings, Inc. (EXPI) Subsidiary eXp Realty Records 178% Increase in Agent Count During 2016

Before the opening bell, eXp World Holdings, Inc. (OTCQB: EXPI) announced final 2016 agent totals for subsidiary eXp Realty LLC, the Agent-Owned Cloud Brokerage®. With 2,401 real estate brokers and agents on its platform at the end of the year, the company achieved a year-over-year increase of 178 percent, or 1,537 members, during 2016. This growth was driven, in part, by eXp Realty’s continued geographic expansion. The company currently operates in 42 states, the District of Columbia and Alberta, Canada. Likewise, in this morning’s update, EXPI attributed the success of eXp Realty to its “unique agent-centric model that allows agents…

WednesdayJan 11, 2017 8:30 am

Senate Banking Committee Could Pave the Way to a Bankable Marijuana Industry

Last month, a letter signed by 10 U.S. senators arrived on the desk of Jamal El-Hindi, the acting director of the Financial Crimes Enforcement Network (FinCEN), requesting guidance on how banking services might be offered to “indirect businesses” – such as SinglePoint, Inc. (OTC: SING), Medical Marijuana, Inc. (OTC: MJNA) and Cannabis Science, Inc. (OTC: CBIS) - that serve the state-sanctioned marijuana industry. The implications of such guidance also carry considerable potential for banking players ranging from small financial institutions to bellwether banks like Bank of America (NYSE: BAC) and Citigroup (NYSE: C). The letter came at the prompting of…

TuesdayJan 10, 2017 3:32 pm

Jaguar Animal Health, Inc. (NASDAQ: JAGX) Given Company Update by Aegis Capital Corp.

Jaguar Animal Health, Inc. (NASDAQ: JAGX), a company in the business of developing and commercializing gastrointestinal products for companion animals, horses, and production animals, recently had its company outlook updated by Aegis Capital Corp. (http://nnw.fm/8Jn4H). The company has been offered a ‘Buy’ rating with a price target of $10 per share. The company update was announced after JAGX made several decisions that Aegis believes could improve the outlook for the company. The company, which is committed to identifying animal health market opportunities to develop products specific to various species, announced that it has proposed a business combination with its parent…

TuesdayJan 10, 2017 1:21 pm

Strong Residential Real Estate Market Bodes Well For eXp World Holdings, Inc. (EXPI)

The market for residential real estate is projected to be strong in 2017 and 2018 by numerous real estate organizations, and that can only be bullish news for Bellingham, Washington-based eXp World Holdings, Inc. (OTCQB: EXPI), the holding company for eXp Realty LLC, the Agent-Owned Cloud Brokerage®. The National Association of Realtors® (NAR) and the National Association of Home Builders® (NAHB) agree that there will be an increase in both existing and new home sales. They may not share the same base numbers in residential real estate, but they both expect positive growth in the two-year period ahead. Lawrence Yun,…

Financial news and publishing for public and private companies

Contact us: 512.354.7000